Document
NDTS (PDF Version)
ICR 201210-1117-001 · OMB 1117-0052 · Object 35282701.
This document may belong to an older filing. More recent activity for OMB 1117-0052:
Document Viewer [docx]
Document Metadata
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
|---|---|
| File Title | NDTS (PDF Version) |
| Author | Wiegand, Francine H. |
| Last Modified By | Writer |
| File Modified | 2012-09-17 |
| File Created | 2026-07-15 |
| Conversion State | complete |
Extracted Text
National Drug Threat Survey 2013 U.S. Department of Justice Drug Enforcement Administration Attn: Fran Wiegand, Project Manager (NDTS) 8701 Morrissette Drive Springfield, VA 22152 Phone: (202) 353-1112 Fax: (202) 307-8955 Please provide the following information: Law Enforcement Agency: Title (of person completing survey): First Name: MI: Last Name: Address: State: Zip: Telephone: Fax: E-mail Address: OMB No.: XXXXXXXXX (Expiration date XXXXXXX) Rev: XXXXXXXXX DEA Form XXXX Greatest Drug Threat and Drug-Related Crime 1. For your jurisdiction, please indicate the drug that poses the greatest threat, the drug that most contributes to violent crime and the drug that most contributes to property crime. (Choose only ONE drug on each list.) Greatest Drug Threat Violent Crime Property Crime (Choose only ONE) (Choose only ONE) (Choose only ONE) 1a. Over the past year, has your agency experienced a significant change in a drug trafficking attribute (availability, demand, distribution, production, transportation) for any of the listed drugs? Please explain by indicating next to the appropriate drug the attribute and whether the change is an increase or decrease. Drug Attribute Change Powder cocaine Crack cocaine Heroin Methamphetamine Marijuana Controlled prescription drugs Bath salts Synthetic cannabinoids Other (specify) Drug Availability 2. Indicate the level of availability of the following drugs in your jurisdiction using the following definitions: Low availability – drug is difficult to obtain most of the time Moderate availability – drug is easily obtained most of the time High availability – drug is easily obtained at any time NA – drug is not available at any time DK – don’t know if drug is available Drug Production 3. Please indicate how cannabis is cultivated in your jurisdiction. (Check ALL that apply.) Indoors Outdoors Hydroponically Not cultivated Don’t know 4. Please indicate the level of methamphetamine production in your jurisdiction. (Check only ONE.) Low production Moderate production High production Not produced Don’t know 4a. If methamphetamine is produced in your jurisdiction, please indicate the past year change in the level of production. Increased Decreased Remained the same Not applicable Don’t know Diversion/Illicit Use of Controlled Prescription Drugs 5. Indicate the levels of diversion and illicit use for the following types of controlled prescription drugs in your jurisdiction. Drug Trafficking Activities 6. What are the racial and/or ethnic backgrounds of organizations that are the principal wholesale drug distributors in your jurisdiction (e.g., African American, Caucasian, Dominican, Hispanic, Mexican)? List up to three types for each drug. Powder Cocaine Crack Cocaine Heroin Methamphetamine Marijuana Controlled prescription drugs Other (specify) 6a. What are the racial and/or ethnic backgrounds of organizations that are the principal retail drug distributors in your jurisdiction (e.g., African American, Caucasian, Dominican, Hispanic, Mexican)? List up to three types for each drug. Powder Cocaine Crack Cocaine Heroin Methamphetamine Marijuana Controlled prescription drugs Other (specify) Thank you for your participation! DEA Headquarters, 8701 Morrissette Drive, Springfield, Virginia 22152 • (202) 353-1112